Urica Therapeutics, Inc. logo

Urica Therapeutics, Inc. jobs and careers

As of October 24, 2026, Urica Therapeutics, Inc. has no open roles listed.

About Urica Therapeutics, Inc.

Urica Therapeutics, Inc. (“Urica”) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and other conditions associated with hyperuricemia. Urica acquired the rights to develop and commercialize Dotinurad, a potentially best-in-class URAT1 inhibitor, in the United States, United Kingdom, European Union, Canada, Middle East and North Africa (MENA) and Turkey from Fuji Yakuhin. Dotinurad has been approved to treat gout and hyperuricemia in Japan and is currently in a Phase 1 clinical trial in the United States. Urica was founded by Fortress Biotech, Inc. (Nasdaq: FBIO).

Founded
2021
Employees
1 to 10
Total funding
$2.5M

Leadership

The top of Urica Therapeutics, Inc.'s org chart, with how many people report into each leader.

JD

Jay D. Kranzler, M.D., Ph.D.

Chairman and Chief Executive Officer

1 report

PBPhoto of Paul Brooke

Paul Brooke

Vice Chairman, Board Of Directors

Jobs at Urica Therapeutics, Inc.

No open positions right now. Explore more companies on TheJobsMap.

Urica Therapeutics, Inc. jobs: common questions

Is Urica Therapeutics, Inc. hiring right now?
Urica Therapeutics, Inc. has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Urica Therapeutics, Inc.'s careers site.
Who leads Urica Therapeutics, Inc.?
Jay D. Kranzler, M.D., Ph.D., Chairman and Chief Executive Officer, is at the top of Urica Therapeutics, Inc.'s org chart.
How do I apply for a job at Urica Therapeutics, Inc.?
Pick a role on Urica Therapeutics, Inc.'s TheJobsMap page and select Apply. Every listing links to the original posting on Urica Therapeutics, Inc.'s own careers site, so you apply directly with the employer.